Faculty Opinions recommendation of The first five years of single-cell cancer genomics and beyond.

Author(s):  
Wafik El-Deiry
2017 ◽  
Vol 42 ◽  
pp. 22-32 ◽  
Author(s):  
Daphne Tsoucas ◽  
Guo-Cheng Yuan

2017 ◽  
Author(s):  
João M. Alves ◽  
David Posada

AbstractBackgroundQuerying cancer genomes at single-cell resolution is expected to provide a powerful framework to understand in detail the dynamics of cancer evolution. However, given the high costs currently associated with single-cell sequencing, together with the inevitable technical noise arising from single-cell genome amplification, cost-effective strategies that maximize the quality of single-cell data are critically needed. Taking advantage of five published single-cell whole-genome and whole-exome cancer datasets, we studied the impact of sequencing depth and sampling effort towards single-cell variant detection, including structural and driver mutations, genotyping accuracy, clonal inference and phylogenetic reconstruction, using recent tools specifically designed for single-cell data.ResultsAltogether, our results suggest that, for relatively large sample sizes (25 or more cells), sequencing single tumor cells at depths >5x does not drastically improve somatic variant discovery, the characterization of clonal genotypes or the estimation of phylogenies from single tumor cells.ConclusionsWe demonstrate that sequencing many individual tumor cells at a modest depth represents an effective alternative to explore the mutational landscape and clonal evolutionary patterns of cancer genomes, without the excessively high costs associated with high-coverage genome sequencing.


2015 ◽  
Vol 25 (10) ◽  
pp. 1499-1507 ◽  
Author(s):  
Nicholas E. Navin

2021 ◽  
Author(s):  
Karla Helvie ◽  
Laura DelloStritto ◽  
Lori Marini ◽  
Nelly Oliver ◽  
Miraj Patel ◽  
...  

This standard operating procedure was established by the Center for Cancer Genomics at Dana-Farber Cancer Institute, the Brigham and Women's Hospital and the Klarman Cell Observatory at the Broad Institute, to standardize the collection of fresh metastatic breast cancer biopsies and their allocation to various bulk and single cell assays, including whole exome and bulk RNA-sequencing, single-cell RNA sequencing, and spatial profiling of RNA and protein. The use of a well defined workflow has allowed us to generate high quality data from these different assays, by implementing efficient modes of communication, minimizing the time elapsed from sample collection to preservation or processing, and ensuring optimal transportation conditions. Visual Abstract


2020 ◽  
Vol 17 (3) ◽  
pp. 302-310 ◽  
Author(s):  
William S. Chen ◽  
Nevena Zivanovic ◽  
David van Dijk ◽  
Guy Wolf ◽  
Bernd Bodenmiller ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document